Primary Focus Mitochondria Biology, one of the R&D investment areas which Astellas focuses on, covers all medical conditions that are impacted by mitochondrial dysfunction, including decreased mitochondrial motility. Unique mitochondrial diseases with severe conditions and with few effective therapeutics are also targeted.
This story video introduces the Primary Focus Lead of Mitochondria Biology, which actively develops therapeutics for various medical conditions associated with mitochondrial dysfunction.
For this story:
https://www.astellas.com/en/stories/science/mitobridge
source
